Cargando…
Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding
Coxsackievirus A16 (CVA16) is an etiologic agent of hand, foot, and mouth disease (HFMD) that affects young children, and although typically self-limited, severe complications, and fatal cases have been reported. Due to the lack of specific medication and vaccines against CVA16, there is currently a...
Autores principales: | Lin, Chien-Ju, Liu, Ching-Hsuan, Wang, Jonathan Y., Lin, Chun-Ching, Li, Yi-Fang, Richardson, Christopher D., Lin, Liang-Tzung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156566/ https://www.ncbi.nlm.nih.gov/pubmed/30254193 http://dx.doi.org/10.1038/s41426-018-0165-3 |
Ejemplares similares
-
Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles
por: Cheng, Hua-Yew, et al.
Publicado: (2011) -
Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity
por: Ren, Jingshan, et al.
Publicado: (2015) -
HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules
por: Saito, Akatsuki, et al.
Publicado: (2021) -
Methanolic Extract of Rhizoma Coptidis Inhibits the Early Viral Entry Steps of Hepatitis C Virus Infection
por: Hung, Ting-Chun, et al.
Publicado: (2018) -
Capsid-Targeted Viral Inactivation: A Novel Tactic for Inhibiting Replication in Viral Infections
por: Zhang, Xingcui, et al.
Publicado: (2016)